AstraZeneca is a British-Swedish biopharmaceutical company with medicine sales in more than 130 countries,...
Barron's on MSN: Organon rides the pharma M&A wave with Sun takeover. The stock sizzles.
Organon rides the pharma M&A wave with Sun takeover. The stock sizzles.
The biggest bargain in big pharma? Probably the best argument against Bristol Myers Squibb being the biggest bargain in big pharma is that several other stocks have even lower valuation metrics.
Pfizer (NYSE: PFE) and AbbVie (NYSE: ABBV) are two pharmaceutical giants that seem to be headed in opposite directions. Pfizer's stock is up by more than 10% this year, while AbbVie's shares have ...
Barron's on MSN: Organon stock surges 31% on sweetened $13 billion takeover offer from Sun Pharma
Organon stock surges 31% on sweetened $13 billion takeover offer from Sun Pharma
The Financial Express: Cipla to Sun Pharma: Nomura rates these 6 pharma stocks, riding the GLP-1 wave, ‘Buy’
Cipla to Sun Pharma: Nomura rates these 6 pharma stocks, riding the GLP-1 wave, ‘Buy’
Twelve of the 15 analysts surveyed by S&P Global ( SPGI +1.32%) in April rated the pharmaceutical stock as a "buy" or "strong buy." There are three specific catalysts that could send Teva stock to $40 ...
The Motley Fool: What to Look for Before Buying a Pharma Stock
The Financial Express: ₹1,000 cr to ₹5,000 cr: 3 pharma stocks to watch for India’s GLP-1 explosion by 2030
₹1,000 cr to ₹5,000 cr: 3 pharma stocks to watch for India’s GLP-1 explosion by 2030
Investors may be wondering if BridgeBio Pharma (NASDAQ: BBIO) still offers value after a strong run, or if most of the upside is already priced in. The stock last closed at US$73.28, with returns of ...